The latest announcement is out from GlaxoSmithKline ( (GB:GSK) ).
GSK commits $30 billion investment in U.S. R&D and manufacturing during Trump’s UK state visit, strengthening its focus on ...
Dame Emma Walmsley will step down as GSK’s chief executive at the end of the year, concluding nine years at the helm of Britain’s second-largest pharmaceuticals company.
The new projects, including AI efforts in Pennsylvania and three other states, are part of the British firm's pledge to ...
It has been about a month since the last earnings report for GSK (GSK). Shares have added about 3.1% in that time frame, underperforming the S&P 500. Will the recent positive trend continue ...
GSK (GSK) American Depository Shares lost ~2% pre-market Wednesday after a new report from Bloomberg Businessweek claimed that the British drugmaker chose to keep quiet on the cancer risks of the ...
GSK PLC hit a new 52-week high, surpassing its previous peak of £15.61, which the company achieved on March 10th.
Central Pennsylvania is part of GSK ‘s recent announcement that it is investing $30 billion in R&D and manufacturing in the ...